NEW YORK & MAINZ, Germany–(BUSINESS WIRE)–Sep 22, 2021–Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has authorized for emergency use a booster dose of the Pfizer-BioNTech COVID-19 Vaccine for individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age whose frequent institutional or occupational exposure to SARS-CoV-2 puts the
https://apnews.com/press-release/business-wire/europe-business-health-germany-coronavirus-pandemic-e781fdb1302c4d8e994f431e9b2a5930
